Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 13.74
(1.63%)
CNY 13.74
(1.63%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.45 Billion CNY | 21.61% |
| 2022 | 2.02 Billion CNY | 20.87% |
| 2021 | 1.67 Billion CNY | 5.85% |
| 2020 | 1.58 Billion CNY | 29.34% |
| 2019 | 1.22 Billion CNY | 3.92% |
| 2018 | 1.17 Billion CNY | 9.31% |
| 2017 | 1.07 Billion CNY | 16.69% |
| 2016 | 921.73 Million CNY | -11.19% |
| 2015 | 1.03 Billion CNY | 24.48% |
| 2014 | 833.74 Million CNY | 34.83% |
| 2013 | 618.38 Million CNY | 35.71% |
| 2012 | 455.65 Million CNY | 39.45% |
| 2011 | 326.74 Million CNY | 55.5% |
| 2010 | 210.13 Million CNY | 45.47% |
| 2009 | 144.44 Million CNY | 112.96% |
| 2008 | 67.82 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.94 Billion CNY | 1.22% |
| 2024 Q2 | 1.91 Billion CNY | -4.17% |
| 2024 Q1 | 2 Billion CNY | -18.62% |
| 2023 FY | 2.45 Billion CNY | 21.61% |
| 2023 Q2 | 2.51 Billion CNY | -10.98% |
| 2023 Q4 | 2.45 Billion CNY | 1.32% |
| 2023 Q3 | 2.42 Billion CNY | -3.41% |
| 2023 Q1 | 2.82 Billion CNY | 39.58% |
| 2022 Q3 | 1.68 Billion CNY | -14.04% |
| 2022 Q1 | 1.67 Billion CNY | 0.07% |
| 2022 Q4 | 2.02 Billion CNY | 20.19% |
| 2022 Q2 | 1.95 Billion CNY | 16.9% |
| 2022 FY | 2.02 Billion CNY | 20.87% |
| 2021 Q3 | 1.61 Billion CNY | -19.14% |
| 2021 FY | 1.67 Billion CNY | 5.85% |
| 2021 Q1 | 1.66 Billion CNY | 5.53% |
| 2021 Q2 | 2 Billion CNY | 20.04% |
| 2021 Q4 | 1.67 Billion CNY | 3.33% |
| 2020 FY | 1.58 Billion CNY | 29.34% |
| 2020 Q4 | 1.58 Billion CNY | 5.02% |
| 2020 Q1 | 1.35 Billion CNY | 10.55% |
| 2020 Q2 | 1.28 Billion CNY | -4.53% |
| 2020 Q3 | 1.5 Billion CNY | 16.7% |
| 2019 Q3 | 1.23 Billion CNY | 4.13% |
| 2019 Q1 | 1.25 Billion CNY | 6.42% |
| 2019 FY | 1.22 Billion CNY | 3.92% |
| 2019 Q4 | 1.22 Billion CNY | -1.12% |
| 2019 Q2 | 1.18 Billion CNY | -5.15% |
| 2018 FY | 1.17 Billion CNY | 9.31% |
| 2018 Q4 | 1.17 Billion CNY | 11.1% |
| 2018 Q3 | 1.05 Billion CNY | 5.26% |
| 2018 Q2 | 1 Billion CNY | 1.53% |
| 2018 Q1 | 990.14 Million CNY | -7.94% |
| 2017 Q2 | 1.05 Billion CNY | 24.1% |
| 2017 Q1 | 853.18 Million CNY | -7.44% |
| 2017 Q4 | 1.07 Billion CNY | 5.38% |
| 2017 FY | 1.07 Billion CNY | 16.69% |
| 2017 Q3 | 1.02 Billion CNY | -3.61% |
| 2016 Q2 | 936.44 Million CNY | -4.18% |
| 2016 Q3 | 922.13 Million CNY | -1.53% |
| 2016 Q4 | 921.73 Million CNY | -0.04% |
| 2016 FY | 921.73 Million CNY | -11.19% |
| 2016 Q1 | 977.27 Million CNY | -5.84% |
| 2015 Q3 | 908.11 Million CNY | 16.02% |
| 2015 FY | 1.03 Billion CNY | 24.48% |
| 2015 Q2 | 782.7 Million CNY | -2.41% |
| 2015 Q1 | 801.99 Million CNY | -3.81% |
| 2015 Q4 | 1.03 Billion CNY | 14.29% |
| 2014 Q3 | 741.7 Million CNY | 21.43% |
| 2014 FY | 833.74 Million CNY | 34.83% |
| 2014 Q4 | 833.74 Million CNY | 12.41% |
| 2014 Q2 | 610.81 Million CNY | 3.35% |
| 2014 Q1 | 591.02 Million CNY | -4.42% |
| 2013 Q4 | 618.38 Million CNY | 23.05% |
| 2013 FY | 618.38 Million CNY | 35.71% |
| 2013 Q1 | 443.14 Million CNY | -2.75% |
| 2013 Q2 | 506.71 Million CNY | 14.34% |
| 2013 Q3 | 502.54 Million CNY | -0.82% |
| 2012 Q4 | 455.65 Million CNY | -1.58% |
| 2012 Q1 | 321.34 Million CNY | -1.65% |
| 2012 Q2 | 375.09 Million CNY | 16.73% |
| 2012 Q3 | 462.96 Million CNY | 23.43% |
| 2012 FY | 455.65 Million CNY | 39.45% |
| 2011 FY | 326.74 Million CNY | 55.5% |
| 2011 Q2 | 197.07 Million CNY | 0.0% |
| 2011 Q3 | 291.22 Million CNY | 47.77% |
| 2011 Q4 | 326.74 Million CNY | 12.2% |
| 2010 Q4 | 210.13 Million CNY | 0.0% |
| 2010 FY | 210.13 Million CNY | 45.47% |
| 2009 FY | 144.44 Million CNY | 112.96% |
| 2008 FY | 67.82 Million CNY | 0.0% |